Product Details
NGAL is a new early marker for acute kidney injury. Levels rise rapidly after renal injury and have been used in a variety of clinical situations including intensive care, emergency medicine, renal transplantation and procedures involving the use of i.v.contrast media and other nephrotoxic agents. Studies have indicated that this marker has the greatest potential for the prediction and monitoring of acute renal injury following cardiac surgery. This potential has now been expanded upon, with development and commercialisation of highly specific ELISA testing kits.
0.1mg
P722-1